Position in VTRS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$77,433,437
+$16,067,182 QoQ
Shares Held
5,731,565
+16.3% QoQ
Ownership
0.492%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 56.485270602357296.ToString("F0")%
Shared 0.ToString("F0")%
None 43.514729397642704.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026JPMORGAN CHASE & CO holds $2,053,486,049 across 61 Drug Manufacturers - Specialty & Generic names. VTRS ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
5,442,067 | $716,937,900 | |
| 2 | ZTS |
Zoetis Inc.
|
3,387,174 | $400,397,831 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,762,744 | $203,693,847 | |
| 4 | ALKS |
Alkermes plc.
|
4,101,789 | $145,039,257 | |
| 5 | HIMS |
Hims & Hers Health, Inc.
|
5,240,816 | $108,799,337 | |
| 6 | HLN |
Haleon plc
|
8,279,468 | $82,877,469 | |
| 7 | VTRS |
Viatris Inc
This page
|
5,731,565 | $77,433,437 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
4,371,378 | $60,543,580 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $77,433,437 | 5,731,565 | Shares | Other | 2026-05-13 | |
| 2025-12-31 | $61,366,255 | 4,929,017 | Shares | Other | 2026-02-11 | |
| 2025-09-30 | $65,888,118 | 6,655,366 | Shares | Other | 2025-11-26 | |
| 2025-06-30 | $56,772,966 | 6,357,556 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $50,434,961 | 5,790,467 | Shares | Other | 2025-05-12 | |
| 2024-12-31 | $55,445,903 | 4,453,487 | Shares | Other | 2025-02-12 | |
| 2024-09-30 | $85,150,380 | 7,334,228 | Shares | Other | 2024-12-26 | |
| 2024-06-30 | $54,055,009 | 5,085,138 | Shares | Other | 2024-12-26 | |
| 2024-03-31 | $102,574,983 | 8,590,870 | Shares | Other | 2024-12-26 | |
| 2023-12-31 | $49,363,307 | 4,558,016 | Shares | Other | 2024-12-26 | |
| 2023-09-30 | $49,399,834 | 5,010,126 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $51,852,081 | 5,195,600 | Shares | Other | 2023-08-11 | |
| 2023-03-31 | $28,237,725 | 2,935,315 | Shares | Sole | 2023-05-18 | |
| 2022-12-31 | $62,581,768 | 5,622,801 | Shares | Other | 2023-02-13 | |
| 2022-09-30 | $33,357,898 | 3,915,247 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $31,387,798 | 2,997,880 | Shares | Other | 2022-08-11 | |
| 2022-03-31 | $66,493,648 | 6,111,549 | Shares | Other | 2022-05-11 | |
| 2021-12-31 | $110,140,351 | 8,140,455 | Shares | Other | 2022-02-11 | |
| 2021-09-30 | $129,300,707 | 9,542,488 | Shares | Other | 2021-11-12 | |
| 2021-06-30 | $115,851,524 | 8,107,175 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $83,064,006 | 5,945,885 | Shares | Other | 2021-05-12 | |
| 2020-12-31 | $137,902,614 | 7,358,731 | Shares | Other | 2021-02-19 | |
| No filing history on record for this holder in this stock. | ||||||